In cardiovascular diseases, RhoGEFs such as ARHGEF1 and LARG contribute to hypertension and aneurysm formation through activation of the Ang II‐induced RhoA/ROCK pathway, leading to endothelial dysfunction. Here, ARHGEF1 is linked to cardiovascular disorder.